Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros

Bases de dados
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
J Nutr ; 141(1): 17-23, 2011 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-21106928

RESUMO

Trigonella foenum-graecum (fenugreek) can ameliorate dyslipidemia, but the detailed mechanism is unclear. In this study, we examined the effects of fenugreek on hepatic lipid metabolism, particularly lipogenesis, which is enhanced in obesity and diabetes, in diabetic obese KK-Ay mice. KK-Ay mice were fed a control high-fat diet (HFD; 60% of energy as fat) (C group) or an HFD containing 0.5% or 2% fenugreek (0.5F and 2.0F groups, respectively) for 4 wk. Hepatic and plasma TG and mRNA expression levels of lipogenic genes were lower in the 2.0F group at 4 wk (P < 0.05), but not in the 0.5F group, than in the C group. The hydrolyzed saponin fraction, but not the saponin fraction per se, in fenugreek inhibited the accumulation of TG in HepG2 cells. We fractionated the hydrolyzed saponin into 15 fractions by HPLC and examined the effect of these fractions on TG accumulation in HepG2 cells. Fraction 11 inhibited TG accumulation in HepG2 cells and we determined by liquid chromatography tandem MS that the active substance contained in fraction 11 is diosgenin. Diosgenin (5 and 10 µmol/L) inhibited the accumulation of TG and the expression of lipogenic genes in HepG2 cells. Moreover, diosgenin inhibited the transactivation of liver-X-receptor-α, as measured using a luciferase assay system and by gel mobility shift assay. These findings suggest that fenugreek ameliorates dyslipidemia by decreasing the hepatic lipid content in diabetic mice and that its effect is mediated by diosgenin. Fenugreek, which contains diosgenin, may be useful for the management of diabetes-related hepatic dyslipidemias.


Assuntos
Diabetes Mellitus/metabolismo , Diosgenina/farmacologia , Fígado/metabolismo , Receptores Nucleares Órfãos/antagonistas & inibidores , Triglicerídeos/metabolismo , Trigonella/química , Animais , Células Hep G2 , Humanos , Hiperlipidemias/tratamento farmacológico , Receptores X do Fígado , Masculino , Camundongos , Camundongos Obesos , Fitoterapia , RNA Mensageiro/análise , Proteína de Ligação a Elemento Regulador de Esterol 1/fisiologia
2.
Sci Rep ; 6: 23779, 2016 Apr 06.
Artigo em Inglês | MEDLINE | ID: mdl-27048847

RESUMO

The onion lachrymatory factor (LF) is produced from trans-S-1-propenyl-L-cysteine sulfoxide (PRENCSO) through successive reactions catalyzed by alliinase (EC 4.4.1.4) and lachrymatory factor synthase (LFS), and is responsible for the tear inducing-property and the pungency of fresh onions. We developed tearless, non-pungent onions non-transgenically by irradiating seeds with neon-ion at 20 Gy. The bulbs obtained from the irradiated seeds and their offspring bulbs produced by selfing were screened by organoleptic assessment of tear-inducing property or HPLC analysis of LF production. After repeated screening and seed production by selfing, two tearless, non-pungent bulbs were identified in the third generation (M3) bulbs. Twenty M4 bulbs obtained from each of them showed no tear-inducing property or pungency when evaluated by 20 sensory panelists. The LF production levels in these bulbs were approximately 7.5-fold lower than those of the normal onion. The low LF production levels were due to reduction in alliinase activity, which was a result of low alliinase mRNA expression (less than 1% of that in the normal onion) and consequent low amounts of the alliinase protein. These tearless, non-pungent onions should be welcomed by all who tear while chopping onions and those who work in facilities where fresh onions are processed.


Assuntos
Oxirredutases Intramoleculares/química , Cebolas/química , Proteínas de Plantas/química , Engenharia de Proteínas/métodos , Sulfóxidos/química , Liases de Carbono-Enxofre/química , Cromatografia Líquida de Alta Pressão , Cisteína/análogos & derivados , Cisteína/química , Ensaio de Imunoadsorção Enzimática , Oxirredutases Intramoleculares/genética , Cebolas/genética , Proteínas de Plantas/genética , Ácido Pirúvico/química , RNA Mensageiro/metabolismo , Sementes/efeitos da radiação , Análise de Sequência de RNA , Lágrimas
3.
J AOAC Int ; 85(5): 1119-26, 2002.
Artigo em Inglês | MEDLINE | ID: mdl-12374412

RESUMO

Novel analytical methods based on real-time quantitative polymerase chain reactions by use of new reference molecules were validated in interlaboratory studies for the quantitation of genetically modified (GM) maize and soy. More than 13 laboratories from Japan, Korea, and the United States participated in the studies. The interlaboratory studies included 2 separate stages: (1) measurement tests of coefficient values, the ratio of recombinant DNA (r-DNA) sequence, and endogenous DNA sequence in the seeds of GM maize and GM soy; and (2) blind tests with 6 pairs of maize and soy samples, including different levels of GM maize or GM soy. Test results showed that the methods are applicable to the specific quantitation of the 5 lines of GM maize and one line of GM soy. After statistical treatment to remove outliers, the repeatability and reproducibility of these methods at a level of 5.0% were <13.7 and 15.9%, respectively. The quantitation limits of the methods were 0.50% for Bt11, T25, and MON810, and 0.10% for GA21, Event176, and Roundup Ready soy. The results of blind tests showed that the numerical information obtained from these methods will contribute to practical analyses for labeling systems of GM crops.


Assuntos
Glycine max/genética , Zea mays/genética , DNA de Plantas/química , DNA de Plantas/genética , DNA de Plantas/isolamento & purificação , Padrões de Referência , Reprodutibilidade dos Testes , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Glycine max/química , Zea mays/química
4.
Mol Nutr Food Res ; 57(7): 1295-9, 2013 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-23681751

RESUMO

Dill, a small annual herb, is widely used as a flavoring agent in dishes including salads. It has been demonstrated that dill extract and its essential oil show hypolipidemic effects in rats. However, the mechanism of these effects has not been elucidated yet. We found that dill seed extract (DSE) activated peroxisome proliferator-activated receptor-α (PPAR-α), an indispensable regulator for hepatic lipid metabolism, by luciferase assay. Thus, we performed DSE feeding experiments using diabetic obese model KK-Ay mice to examine the effects of DSE on PPAR-α activation in vivo. A 4-week feeding of DSE contained in a high-fat diet decreased plasma triacylglyceride and glucose levels and increased the mRNA expression levels of fatty acid oxidation-related genes in the liver. In addition, the DSE feeding as well as bezafibrate (a PPAR-α potent agonist) feeding increased oxygen consumption rate and rectal temperature. These results indicate that DSE suppresses high-fat diet-induced hyperlipidemia through hepatic PPAR-α activation.


Assuntos
Anethum graveolens/química , Metabolismo dos Lipídeos/efeitos dos fármacos , PPAR alfa/metabolismo , Extratos Vegetais/farmacologia , Sementes/química , Animais , Glicemia/análise , Diabetes Mellitus Experimental/metabolismo , Dieta Hiperlipídica , Hiperlipidemias/prevenção & controle , Fígado/efeitos dos fármacos , Fígado/metabolismo , Camundongos , Camundongos Obesos , PPAR alfa/genética , Triglicerídeos/sangue
5.
G3 (Bethesda) ; 2(6): 643-51, 2012 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-22690373

RESUMO

Lachrymatory factor synthase (LFS) catalyzes the formation of lachrymatory factor, one of the most distinctive traits of bulb onion (Allium cepa L.). Therefore, we used LFS as a model for a functional gene in a huge genome, and we examined the chromosomal organization of LFS in A. cepa by multiple approaches. The first-level analysis completed the chromosomal assignment of LFS gene to chromosome 5 of A. cepa via the use of a complete set of A. fistulosum-shallot (A. cepa L. Aggregatum group) monosomic addition lines. Subsequent use of an F(2) mapping population from the interspecific cross A. cepa × A. roylei confirmed the assignment of an LFS locus to this chromosome. Sequence comparison of two BAC clones bearing LFS genes, LFS amplicons from diverse germplasm, and expressed sequences from a doubled haploid line revealed variation consistent with duplicated LFS genes. Furthermore, the BAC-FISH study using the two BAC clones as a probe showed that LFS genes are localized in the proximal region of the long arm of the chromosome. These results suggested that LFS in A. cepa is transcribed from at least two loci and that they are localized on chromosome 5.

6.
Mol Nutr Food Res ; 54(11): 1596-608, 2010 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-20540147

RESUMO

In obesity, adipocyte hypertrophy and chronic inflammation in adipose tissues cause insulin resistance and type-2 diabetes. Trigonella foenum-graecum (fenugreek) can ameliorate hyperglycemia and diabetes. However, the effects of fenugreek on adipocyte size and inflammation in adipose tissues have not been demonstrated. In this study, we determined the effects of fenugreek on adipocyte size and inflammation in adipose tissues in diabetic obese KK-Ay mice, and identified the active substance in fenugreek. Treatment of KK-Ay mice with a high fat diet supplemented with 2% fenugreek ameliorated diabetes. Moreover, fenugreek miniaturized the adipocytes and increased the mRNA expression levels of differentiation-related genes in adipose tissues. Fenugreek also inhibited macrophage infiltration into adipose tissues and decreased the mRNA expression levels of inflammatory genes. In addition, we identified diosgenin, a major aglycone of saponins in fenugreek to promote adipocyte differentiation and to inhibit expressions of several molecular candidates associated with inflammation in 3T3-L1 cells. These results suggest that fenugreek ameliorated diabetes by promoting adipocyte differentiation and inhibiting inflammation in adipose tissues, and its effects are mediated by diosgenin. Fenugreek containing diosgenin may be useful for ameliorating the glucose metabolic disorder associated with obesity.


Assuntos
Adipócitos/citologia , Tecido Adiposo/efeitos dos fármacos , Diosgenina/farmacologia , Inflamação/tratamento farmacológico , Obesidade/terapia , Extratos Vegetais/farmacologia , Células 3T3-L1 , Adipócitos/metabolismo , Animais , Glicemia/metabolismo , Diferenciação Celular , Modelos Animais de Doenças , Glucose/metabolismo , Resistência à Insulina , Masculino , Camundongos , Camundongos Obesos , Fitoterapia , RNA Mensageiro/metabolismo , Saponinas/análise , Trigonella
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA